What are the types of cancer clinical trials?
Four main types: treatment, prevention, screening, and supportive or palliative care. Each answers a different research question, and knowing which type you are being offered tells you a lot about what to expect.
Treatment trials
Most cancer clinical trials are treatment studies, and they enroll people who have cancer. They test new treatments, or new ways of using treatments that already exist.
These are the trials with phases. A phase 1 trial asks whether a new treatment is safe, what its side effects are, and what the highest tolerable dose is, usually in about 15 to 30 people. A phase 2 trial enrolls more, roughly 50 to 100, and looks at whether the treatment seems to work against the cancer while safety study continues. A phase 3 trial compares the treatment against current standard therapy in 100 to several thousand people, with random assignment to groups. A phase 4 trial follows long-term safety and effectiveness after FDA approval, in large and varied populations.
Results from phases 1 through 3 are what agencies such as the FDA use to decide on approvals.
Prevention and screening trials
Prevention trials look at ways to stop cancer from developing. Most people who join do not have cancer, but they are at high risk of it. Others have had cancer and are at high risk of a new one. There is a design difference here that catches people out. Placebos are rare in cancer treatment trials but turn up more often in prevention trials, because there may be nothing standard to compare against.
Screening trials test ways to find cancer before it causes symptoms, when it may be easier to treat. Healthy volunteers often take part.
Screening research asks a harder question than it sounds. Finding more cancer is not automatically a win, because some cancers found early would never have caused a problem. That is called overdiagnosis, and it is one reason screening studies run for many years before anyone changes a guideline.
Supportive and palliative care trials
These study ways to improve quality of life, especially for people dealing with side effects of cancer and its treatment. Nausea, pain, fatigue, neuropathy, and distress are all studied this way.
They are the least talked-about category and often the easiest to join. If a symptom is wearing you down, it is reasonable to ask whether a supportive care study is open at your center.
What the type tells you
Once you know the type and phase, several practical things follow.
A phase 1 treatment trial is chiefly about dose and safety, so the chance that it helps you personally is lower than in a later-phase study. NCI says plainly that for people with end-stage cancer offered early-phase trials, the chance the new treatment benefits them is low. Some join anyway, hoping to slow the cancer or to help future patients. Both are legitimate reasons, but they are different reasons, and it helps to know which is yours.
A phase 3 trial will randomize you, so you cannot pick your group. A prevention or screening trial may run for years with few visits. A supportive care trial may fit alongside whatever treatment you are already having.
Ask which type and phase a study is at the pre-screening meeting, before consent, along with what the trial covers financially. Our overview of what clinical trials are explains the whole process, and the guide to clinical trial phases covers what each phase asks.
Sources
Want the full picture? Read our complete explanation: What Are Clinical Trials?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.